Tilbroquinol

An overview of the antiparasitic drug Tilbroquinol

Tilbroquinol is an antiparasitic medication primarily used in the treatment of amoebiasis, an infection caused by the Entamoeba histolytica parasite. It is known for its effectiveness in eliminating the cyst and trophozoite forms of the parasite in the intestinal tract.

Mechanism of Action

Tilbroquinol works by interfering with the metabolic processes of the Entamoeba histolytica parasite. It disrupts the DNA synthesis and cellular respiration of the parasite, leading to its death. This action helps in clearing the infection from the gastrointestinal tract.

Pharmacokinetics

Tilbroquinol is administered orally and is absorbed in the gastrointestinal tract. It is distributed throughout the body and reaches high concentrations in the liver, where the Entamoeba histolytica often resides. The drug is metabolized in the liver and excreted primarily through the bile and feces.

Clinical Uses

Tilbroquinol is used in the treatment of:

• Amoebic dysentery
• Amoebic liver abscess
• Intestinal amoebiasis

It is often prescribed in combination with other antiparasitic agents to ensure the complete eradication of the parasite from the body.

Side Effects

Common side effects of Tilbroquinol include:

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain

In rare cases, patients may experience allergic reactions such as rash, itching, or swelling.

Contraindications

Tilbroquinol should not be used in individuals with known hypersensitivity to the drug. Caution is advised in patients with liver disease or renal impairment.

Related Pages

• Amoebiasis
• Antiparasitic drugs
• Entamoeba histolytica
• Gastrointestinal tract infections